Here at the Todd and Karen Wanek Family Program for HLHS we are excited to announce that we are now able to collect, process, and store umbilical cord blood (UCB) from HLHS babies to be potentially used for clinical trials in the future.
After a baby is born and the umbilical cord is cut, the leftover blood that remains in the blood vessels of the placenta and in the portion of the umbilical cord attached to it is known as UCB. The blood from a newborn’s umbilical cord must be collected immediately after delivery and can be preserved privately, donated for public use, or preserved for a specific purpose, depending on a family’s wishes.
Our program has a clinical trial aimed at strengthening the heart using autologous stem cells, or stem cells collected from an individual’s own body. Once the UCB cells have been collected, they are processed and can then be injected back into the body during the Glenn procedure. To learn more about the clinical trial, watch the video below or contact us at HLHS@mayo.edu.
The Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS) is a collaborative network of specialists bonded by the vision of delaying or preventing heart failure for individuals affected by congenital heart defects including HLHS. The specialized team is addressing the various aspects of these defects by using research and clinical strategies ranging from basic science to diagnostic imaging to regenerative therapies. Contact the program at HLHS@mayo.edu.